Read + Share
Amedeo Smart
Independent Medical Education
Allard P, Alhaj N, Lobitz S, Cario H, et al. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea. Haematologica 2022;107:1577-1588.PMID: 34706496
Email
LinkedIn
Facebook
Twitter
Privacy Policy